—
C+
C+ The full Closelook — membership. Open the C+ overview

Twist Bioscience Corp (TWST) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Twist Bioscience Corp

TWST in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Twist Bioscience makes synthetic DNA to order, producing genes, gene fragments and oligo pools used in drug discovery, diagnostics, gene editing and data-storage research. It also sells sequencing tools such as library-preparation kits and exome panels, and viral reference controls used to build test assays. Customers include biotech, pharmaceutical, industrial and agricultural firms as well as academic labs. It is based in South San Francisco and listed in the United States.
Where it sits in the stack
Twist sits in the healthcare sector, within biotechnology, rather than in any Closelook index sleeve; it belongs to the diary's wider life-sciences coverage rather than the AI hardware stack.
Who it is priced against
The diary has no formal peer group for it yet; the market commonly places it alongside broader synthetic-biology and genomics-tools suppliers such as Thermo Fisher Scientific.
Why Closelook tracks it
Twist carries no Closelook index seat and no score in the diary yet, and it has not appeared in any Closelook edition or quote so far.
What the diary watches
Whether the stock's run well above its own recent trading range holds after analysts initiated coverage with a Sell rating, and how the shares behave near their prior high.

Twist Bioscience Corp (TWST) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for TWST, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 2 analyst actions on the wire · latest: price target by Leerink, 2026-09-17

The Street on this name

Analyst actions and the latest print for TWST from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target Leerink — target 160 from 120 Target raised to $160 from $120 (+11.8% to spot) 2026-09-17
  • Initiation BWS Financial — at Sell Initiated to Sell 2026-09-09

2 actions on the analyst wire since 2026-08-13: 1 initiation, 1 target change. Analyst wire → · Earnings wire →

Who it is priced against Biotechnology · US · 8 names with week and year-to-date

Peer group

Biotechnology · US

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against TWST on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Twist Bioscience Corp (TWST)?

Twist Bioscience Corp trades as TWST on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-19.

Is TWST in a Closelook index?

Not currently — Twist Bioscience Corp is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does TWST trade against its moving averages?

Uptrend stack intact: Trades +41.1% vs the 50-day and +139.6% vs the 200-day average, 0% below the 52-week high and +616.7% off the 52-week low. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Twist Bioscience Corp do?

Twist Bioscience makes synthetic DNA to order, producing genes, gene fragments and oligo pools used in drug discovery, diagnostics, gene editing and data-storage research. It also sells sequencing tools such as library-preparation kits and exome panels, and viral reference controls used to build test assays. Customers include biotech, pharmaceutical, industrial and agricultural firms as well as academic labs. The diary has no formal peer group for it yet; the market commonly places it alongside broader synthetic-biology and genomics-tools suppliers such as Thermo Fisher Scientific.

Where does Twist Bioscience Corp sit in the AI build-out?

Twist sits in the healthcare sector, within biotechnology, rather than in any Closelook index sleeve; it belongs to the diary's wider life-sciences coverage rather than the AI hardware stack. Twist carries no Closelook index seat and no score in the diary yet, and it has not appeared in any Closelook edition or quote so far.

What has Wall Street done on Twist Bioscience Corp recently?

The most recent analyst action on Twist Bioscience Corp on the Closelook wire is a price target by Leerink on 2026-09-17 (target 160 from 120). 2 actions on the analyst wire since 2026-08-13: 1 initiation, 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TWST, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.